Tag:
Precision Therapeutics
Latest Headlines
Latest Headlines
Precision Therapeutics gets $33M to support ChemoFx
Pittsburgh-based Precision Therapeutics has landed a $33 million venture capital round, with Bain Capital leading the Series D funding round. "That's twice what we shot for," said CEO Sean McDonald,
Dx company Veracyte lands $28M series B
With the help of several blue-chip firms, including lead investor Domain Associates, South San Francisco-based Veracyte has announced it has closed a $28 million Series B round. Previous investors
Four companies gain VC funds
Precision Therapeutics has booked up $43 million in a sixth round of funding. The money will be used to expand the development and commercialization of ChemoFx, a lab test that predicts how patient's
ALSO NOTED: Novartis licenses MedImmune vaccine IP; Rumor Mill: Dr. Reddy bids for Bradley; and much more...
> Rumor Mill:Â Generic drugmaker Dr. Reddy's Laboratories is said to have submitted a bid for U.S.-based Bradley Pharma.
